Australian Broker Call *Extra* Edition – Aug 02, 2022

This story features ACCENT GROUP LIMITED, and other companies. For more info SHARE ANALYSIS: AX1

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

AX1   BCB   CBO   DMP   DTC   EML (2)   FLT   IGO   IKE   MIN   NAN (4)   NXS   OZL (3)   S32   SDV   STO   TLX   WDS   WSP (2)  

AX1    ACCENT GROUP LIMITED

Apparel & Footwear – Overnight Price: $1.31

Bell Potter rates ((AX1)) as Buy (1) –

Accent Group's trading update suggests earnings missed consensus by -7% to -10% as softer consumer spending and issues with new product availability bit.

But the result broadly met Bell Potter's forecasts and the broker notes a recovery in product delivery in the first few weeks of FY23 combined with good like-for-like sales.

Buy rating retained. Target price falls to $1.90 a share from $2.20 to reflect Bell Potter's expectations of softer consumer spending across FY23.

This report was published on July 26, 2022.

Target price is $1.90 Current Price is $1.31 Difference: $0.59
If AX1 meets the Bell Potter target it will return approximately 45% (excluding dividends, fees and charges).
Current consensus price target is $1.41, suggesting upside of 7.3%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Bell Potter forecasts a full year FY22 dividend of 5.70 cents and EPS of 7.00 cents.
At the last closing share price the estimated dividend yield is 4.35%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.71.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 7.0, implying annual growth of -50.7%.
Current consensus DPS estimate is 5.3, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 18.7.

Forecast for FY23:

Bell Potter forecasts a full year FY23 dividend of 9.00 cents and EPS of 11.50 cents.
At the last closing share price the estimated dividend yield is 6.87%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.39.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 11.2, implying annual growth of 60.0%.
Current consensus DPS estimate is 8.5, implying a prospective dividend yield of 6.5%.
Current consensus EPS estimate suggests the PER is 11.7.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BCB    BOWEN COKING COAL LIMITED

Coal – Overnight Price: $0.28

Shaw and Partners rates ((BCB)) as Buy (1) –

Shaw and Partners notes Bowen Coking Coal announced the start of coal mining from Broadmeadow East, adding to the initial production at Bluff which was reported earlier in July.

Bowen Coking Coal has the capacity to produce up to 4-5Mtpa over the next 2-3 years and should be well supported by elevated coal prices from supply shortages, explains the broker

Buy rating and a $0.51 price target.

This report was published on July 22, 2022.

Target price is $0.51 Current Price is $0.28 Difference: $0.23
If BCB meets the Shaw and Partners target it will return approximately 82% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY22:

Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 40.00.

Forecast for FY23:

Shaw and Partners forecasts a full year FY23 EPS of 11.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 2.46.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CBO    COBRAM ESTATE OLIVES LIMITED

Agriculture – Overnight Price: $1.40

Bell Potter rates ((CBO)) as Buy (1) –

Bell Potter notes EU extra virgin olive oil prices have risen 24% in the year to end of May. Back in Oz, urea prices have fallen -40% in recent weeks, as have other ag-chem's ingredients and water allocation prices.

The broker says the fall in input costs, combined with rising farmgate prices, suggest the worst may be behind the company.

Australian crop forecasts outpaced the broker, and Bell Potter estimates this translates to a $3m beat in crop valuation – partially offset by US losses. 

The broker notes Cobram Estate Olives has announced double digit US price increases which should ameliorate this.

Earnings (EBITDA) forecasts fall -8% in FY22, -5% in FY23 and -5% in FY24. Buy rating retained. Target price falls to $2 from $2.20.

This report was published on July 26, 2022.

Target price is $2.00 Current Price is $1.40 Difference: $0.6
If CBO meets the Bell Potter target it will return approximately 43% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY22:

Bell Potter forecasts a full year FY22 dividend of 3.30 cents and EPS of 0.70 cents.
At the last closing share price the estimated dividend yield is 2.36%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 200.00.

Forecast for FY23:

Bell Potter forecasts a full year FY23 dividend of 3.30 cents and EPS of 9.60 cents.
At the last closing share price the estimated dividend yield is 2.36%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.58.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

DMP    DOMINO'S PIZZA ENTERPRISES LIMITED

Food, Beverages & Tobacco – Overnight Price: $72.12

Goldman Sachs rates ((DMP)) as Sell (5) –

Goldman Sachs retains its Sell rating for Domino's Pizza Enterprises after looking at 2Q results for the global master franchisor in the US. The results showed better US same store sales (SSS) though weaker unit growth, while International SSS disappointed.

Locally, the broker expects weaker store roll-outs given challenged franchisee payback periods and decreased margins as COGS inflation can't be fully passed through. The $59.20 target price is unchanged.

Apart from some adverse exchange rates upon translation, the analyst also sees transaction risk from the Japanese currency, as Japan imports a material portion of COGS in US dollars.

This report was published on July 25, 2022.

Target price is $59.20 Current Price is $72.12 Difference: minus $12.92 (current price is over target).
If DMP meets the Goldman Sachs target it will return approximately minus 18% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $89.19, suggesting upside of 23.7%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Goldman Sachs forecasts a full year FY22 dividend of 146.00 cents and EPS of 183.00 cents.
At the last closing share price the estimated dividend yield is 2.02%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 39.41.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 203.8, implying annual growth of -4.2%.
Current consensus DPS estimate is 165.5, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 35.4.

Forecast for FY23:

Goldman Sachs forecasts a full year FY23 dividend of 150.00 cents and EPS of 187.00 cents.
At the last closing share price the estimated dividend yield is 2.08%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 38.57.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 232.2, implying annual growth of 13.9%.
Current consensus DPS estimate is 184.5, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 31.1.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

DTC    DAMSTRA HOLDINGS LIMITED

Software & Services – Overnight Price: $0.25

Wilsons rates ((DTC)) as Market Weight (3) –

Damstra Holdings' June-quarter update fell short of consensus and Wilsons' forecasts and just shy of guidance.

Metrics were good, particularly the reduction in cash burn and management guided to a further improvement in the second half thanks to an increase in the cost optimisation program to $8m.

Damstra now expects to be cash flow positive in the second half of 2023. Meanwhile, contract wins continued apace as flagged.

Wilsons notes Damstra has resorted to debt funding to carry operations possibly through to breakeven.

MarketWeight rating and 20c target price are under review.

This report was published on July 25, 2022.

Target price is $0.20 Current Price is $0.25 Difference: minus $0.05 (current price is over target).
If DTC meets the Wilsons target it will return approximately minus 20% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company's fiscal year ends in June.

Forecast for FY22:

Wilsons forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 2.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 11.36.

Forecast for FY23:

Wilsons forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 7.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 3.21.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

EML    EML PAYMENTS LIMITED

Business & Consumer Credit – Overnight Price: $1.01

Canaccord Genuity rates ((EML)) as Hold (3) –

Canaccord Genuity had kept its earnings estimates for EML Payments materially below the consensus expectation throughout the Central Bank of Ireland's regulatory review process.

This was good foresight as the company has not passed its long-awaited remediation review. The broker now continues with its Hold rating given the potential for ongoing negative consensus earnings revisions.

This negative view is offset, acknowledges the analyst, by potential for a change-of-control transaction following the resignation of the previous founder and expressions of interest by third parties. The $1.50 target price is unchanged.

This report was published on July 26, 2022.

Target price is $1.50 Current Price is $1.01 Difference: $0.49
If EML meets the Canaccord Genuity target it will return approximately 49% (excluding dividends, fees and charges).
Current consensus price target is $2.48, suggesting upside of 145.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of 7.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.12.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 4.5, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 22.4.

Forecast for FY23:

Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of 7.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.43.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 7.8, implying annual growth of 73.3%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 12.9.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Wilsons rates ((EML)) as Under Review (1) –

EML Payments updated the market on the Central Bank of Ireland remediation timetable.

Wilsons highlighted the share price fell -22% on news of the ongoing uncertainty in timing for the remediation process, as well as rising costs impacting on future earnings.

Accordingly, the analyst is reviewing earnings forecasts for FY23 in particular.

Overweight rating and  $2.24 price target are both under review.

This report was published on July 26, 2022.

Target price is $2.24 Current Price is $1.01 Difference: $1.23
If EML meets the Wilsons target it will return approximately 122% (excluding dividends, fees and charges).
Current consensus price target is $2.48, suggesting upside of 145.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Wilsons forecasts a full year FY22 dividend of 0.00 cents and EPS of 7.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.03.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 4.5, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 22.4.

Forecast for FY23:

Wilsons forecasts a full year FY23 dividend of 0.00 cents and EPS of 10.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.35.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 7.8, implying annual growth of 73.3%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 12.9.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

FLT    FLIGHT CENTRE TRAVEL GROUP LIMITED

Travel, Leisure & Tourism – Overnight Price: $17.06

Goldman Sachs rates ((FLT)) as Neutral (3) –

Flight Centre Travel upgraded FY22 earnings (EBITDA) to a reduced loss, implying breakeven in the December half, notes Goldman Sachs.

This outpaced Goldman Sachs' and consensus forecasts.

Meanwhile, the broker notes international travel continued to rise in the June quarter, while domestic travel has settled at 80% of pre-covid levels.

Neutral rating retained. Target price rises 18.6% to $20.90.

This report was published on July 25, 2022.

Target price is $20.90 Current Price is $17.06 Difference: $3.84
If FLT meets the Goldman Sachs target it will return approximately 23% (excluding dividends, fees and charges).
Current consensus price target is $16.50, suggesting downside of -3.3%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Goldman Sachs forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 115.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 14.78.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -127.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY23:

Goldman Sachs forecasts a full year FY23 dividend of 0.00 cents and EPS of 69.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.58.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 31.3, implying annual growth of N/A.
Current consensus DPS estimate is 10.1, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 54.5.

Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IGO    IGO LIMITED

Nickel – Overnight Price: $11.05

JP Morgan rates ((IGO)) as Overweight (1) –

While 4Q earnings (EBITDA) for IGO were 11% ahead of JP Morgan's forecast on stronger production at Greenbushes and lower costs (Nova costs also lower than expected), FY23 guidance is seen as mixed.

FY23 capex guidance of -$420-480m was a negative surprise for the broker, compared to its -$370m prediction. The ramp-up at the Kwinana lithium hydroxide refinery is also taking longer than expected, with commercial production expected by Christmas.

The target price falls to $13.70 from $15.50 and the Overweight rating is unchanged.

This report was published on July 28, 2022.

Target price is $13.70 Current Price is $11.05 Difference: $2.65
If IGO meets the JP Morgan target it will return approximately 24% (excluding dividends, fees and charges).
Current consensus price target is $12.60, suggesting upside of 14.0%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

JP Morgan forecasts a full year FY22 dividend of 9.00 cents and EPS of 51.00 cents.
At the last closing share price the estimated dividend yield is 0.81%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.67.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 53.5, implying annual growth of 121.5%.
Current consensus DPS estimate is 11.3, implying a prospective dividend yield of 1.0%.
Current consensus EPS estimate suggests the PER is 20.7.

Forecast for FY23:

JP Morgan forecasts a full year FY23 dividend of 105.00 cents and EPS of 219.00 cents.
At the last closing share price the estimated dividend yield is 9.50%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.05.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 189.8, implying annual growth of 254.8%.
Current consensus DPS estimate is 47.1, implying a prospective dividend yield of 4.3%.
Current consensus EPS estimate suggests the PER is 5.8.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IKE    IKEGPS GROUP LIMITED

Hardware & Equipment – Overnight Price: $0.75

Bell Potter rates ((IKE)) as Buy (1) –

ikeGPS Group's June-quarter trading update pleased Bell Potter, the company logging strong transaction and subscription revenue and another $8m in contract wins. But lower transaction margins caused a profit miss.

The broker admires the company's solid balance and relatively low cash burn, not to mention a NZ$13m to NZ$15m contract backlog, which accounts for the majority of the broker's upgraded revenue forecast.

Buy rating reiterated. Target price rises to 96c from 88c.

This report was published on July 21, 2022.

Target price is $0.96 Current Price is $0.75 Difference: $0.21
If IKE meets the Bell Potter target it will return approximately 28% (excluding dividends, fees and charges).
The company's fiscal year ends in March.

Forecast for FY23:

Bell Potter forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 3.55 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 21.12.

Forecast for FY24:

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MIN    MINERAL RESOURCES LIMITED

Iron Ore – Overnight Price: $53.96

Bell Potter rates ((MIN)) as Buy (1) –

Mineral Resources management has guided to an increase in lithium spodumene concentrates for FY22 and Bell Potter adjusts forecasts accordingly.

The company expects lithium-products production to rise across FY23 and FY24 thanks to mine reopenings, plant expansions and other value-add options.

Given strong demand and high prices, the broker expects a 200% step-up in earnings growth to more than $2.3bn from $750m in FY23.

EPS forecasts falls -34% in FY22 before rising 22% in FY23 and 95% in FY24.

Buy rating retained. Target price rises to $75 from $70, the broker believing the lithium business will start yielding strong returns from FY23.

This report was published on July 25, 2022.

Target price is $75.00 Current Price is $53.96 Difference: $21.04
If MIN meets the Bell Potter target it will return approximately 39% (excluding dividends, fees and charges).
Current consensus price target is $73.34, suggesting upside of 35.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Bell Potter forecasts a full year FY22 dividend of 40.90 cents and EPS of 127.40 cents.
At the last closing share price the estimated dividend yield is 0.76%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 42.35.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 259.1, implying annual growth of -61.5%.
Current consensus DPS estimate is 120.1, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 20.8.

Forecast for FY23:

Bell Potter forecasts a full year FY23 dividend of 96.00 cents and EPS of 669.90 cents.
At the last closing share price the estimated dividend yield is 1.78%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.05.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 1193.5, implying annual growth of 360.6%.
Current consensus DPS estimate is 508.4, implying a prospective dividend yield of 9.4%.
Current consensus EPS estimate suggests the PER is 4.5.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NAN    NANOSONICS LIMITED

Medical Equipment & Devices – Overnight Price: $4.62

Bell Potter rates ((NAN)) as Hold (3) –

Nanosonics has guided to higher revenue growth, alleviating concerns that the transition from GE Health as a distributor to reseller of Trophon would hurt sales, says Bell Potter.

FY22 revenue guidance outpaced the broker's forecast by 3%. Hold rating retained. Target price inches up to $4.05 from $3.95.

This report was published on July 25, 2022.

Target price is $4.05 Current Price is $4.62 Difference: minus $0.57 (current price is over target).
If NAN meets the Bell Potter target it will return approximately minus 12% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $4.14, suggesting downside of -10.5%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Bell Potter forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 1.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 462.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -0.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY23:

Bell Potter forecasts a full year FY23 dividend of 0.00 cents and EPS of 5.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 92.40.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 2.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 210.0.

Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Canaccord Genuity rates ((NAN)) as Buy (1) –

Nanosonics has upgraded its FY22 revenue guidance to $120.3m from $115.6m, which beats Canaccord Genuity's above-market estimate for $116.9m.

In the early transition phase from relying on General Electric to close sales, the broker highlights around 91% of all new installed units in the 4Q came via the Nanosonics sales team.

Management noted customers had transitioned successfully and that shipping volumes via the Nanosonics facility in Indianapolis had increased over 100% by comparison to the pre-transition period.

The target price rises to $4.89 from $4.78 and the Buy rating is maintained.

This report was published on July 27, 2022.

Target price is $4.89 Current Price is $4.62 Difference: $0.27
If NAN meets the Canaccord Genuity target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $4.14, suggesting downside of -10.5%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 1.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 462.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -0.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY23:

Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of 2.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 177.69.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 2.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 210.0.

Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Goldman Sachs rates ((NAN)) as Sell (5) –

Nanosonics's FY22 revenue update outpaced consensus by 4% but cost details will be revealed at the results on August.

The company reports no disruption to the continuity of supply.

While Goldman Sachs considers the result ambiguous, the broker reads it as a small positive.

But with plenty of headwinds and given the company trades on a high multiple, the broker retains a Sell rating and $3.20 target price.

This report was published on July 25, 2022.

Target price is $3.20 Current Price is $4.62 Difference: minus $1.42 (current price is over target).
If NAN meets the Goldman Sachs target it will return approximately minus 31% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $4.14, suggesting downside of -10.5%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Goldman Sachs forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 2.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 231.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -0.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY23:

Goldman Sachs forecasts a full year FY23 dividend of 0.00 cents and EPS of 3.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 154.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 2.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 210.0.

Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Wilsons rates ((NAN)) as Overweight (1) –

Nanosonics pre-announced FY22 sales revenue growth of 17% (yoy) to $120m which was above both consensus and Wilsons forecast.

Encouragingly the new Trophon volume sales grew over the previous period, lending support to a successful changeover in marketing from GE to Nanosonics, the broker suggests.

Wilsons will review the earnings forecasts following the FY22 results announcement on August 23.

The Overweight rating and target price of $7.00 are retained.

This report was published on July 29, 2022.

Target price is $7.00 Current Price is $4.62 Difference: $2.38
If NAN meets the Wilsons target it will return approximately 52% (excluding dividends, fees and charges).
Current consensus price target is $4.14, suggesting downside of -10.5%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Wilsons forecasts a full year FY22 dividend of 0.00 cents and EPS of 1.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 243.16.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -0.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY23:

Wilsons forecasts a full year FY23 dividend of 0.00 cents and EPS of 4.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 102.67.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 2.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 210.0.

Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NXS    NEXT SCIENCE LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $1.00

Canaccord Genuity rates ((NXS)) as Buy (1) –

Next Science's reported June quarter trading results came in below Canaccord Genuity's expectations with sales revenue up around 70% on the previous quarter, but missing 1H22 forecasts.

The broker highlights the miss is largely attributable to the ongoing covid-related problems and staff shortages in the US healthcare system.

Of concern, noted the analyst, was the cash burn which reached -US$3.5m in the quarter and post a second capital raising, cash reserves sit at some US$11m.

Looking ahead, revenues are forecast to double and and the first order for Zimmer should be booked in 3Q22, according to the analyst.

A Buy rating is maintained with a $2.01 price target.

This report was published on July 26, 2022.

Target price is $2.01 Current Price is $1.00 Difference: $1.01
If NXS meets the Canaccord Genuity target it will return approximately 101% (excluding dividends, fees and charges).
The company's fiscal year ends in December.

Forecast for FY22:

Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 6.24 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 16.03.

Forecast for FY23:

Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of 7.21 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.87.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

OZL    OZ MINERALS LIMITED

Copper – Overnight Price: $18.91

Bell Potter rates ((OZL)) as Buy (1) –

OZ Minerals' June-quarter production missed Bell Potter's forecasts and costs were in line.

While management was optimistic of a recovery, the broker notes this will require strong improvements across all metrics to meet recent guidance.

The broker appreciates the balance sheet but expects a debt draw-down during the quarter. Combined with a larger debt facility and sizeable capital expenditure program these are signs of growing pressure, points out the analyst.

2022 earnings forecasts fall -24% to reflect lower commodity prices and higher cash costs, only slightly relieved by beneficial FX movements. 2023 and 2024 earnings forecasts fall -11% and -14%.

Buy rating retained. Target price falls -7% to $24.45 from $26.17.

This report was published on July 25, 2022.

Target price is $24.45 Current Price is $18.91 Difference: $5.54
If OZL meets the Bell Potter target it will return approximately 29% (excluding dividends, fees and charges).
Current consensus price target is $19.12, suggesting upside of 1.1%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY22:

Bell Potter forecasts a full year FY22 dividend of 16.00 cents and EPS of 103.00 cents.
At the last closing share price the estimated dividend yield is 0.85%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.36.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 109.3, implying annual growth of -31.5%.
Current consensus DPS estimate is 21.4, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 17.3.

Forecast for FY23:

Bell Potter forecasts a full year FY23 dividend of 18.00 cents and EPS of 120.80 cents.
At the last closing share price the estimated dividend yield is 0.95%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.65.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 117.0, implying annual growth of 7.0%.
Current consensus DPS estimate is 20.9, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 16.2.

Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Canaccord Genuity rates ((OZL)) as Buy (1) –

OZ Minerals reported a June quarter production miss for copper (-10% on the previous quarter) due to ore handling problems at Carrapateena, poor weather and absenteeism, highlighted Canaccord Genuity.

Gold production was up 5% and net cash came in below estimates at $82m with higher tax payments offsetting the lower capital expenditure and operating cash flows.

Canaccord Genuity adjusts the FY22 earnings forecasts for the updates and earnings before interest, depreciation and tax reduce by -26% for FY22.

A Buy rating is retained and the price target is lowered to $20.50 from $22.

This report was published on July 26, 2022.

Target price is $20.50 Current Price is $18.91 Difference: $1.59
If OZL meets the Canaccord Genuity target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $19.12, suggesting upside of 1.1%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY22:

Canaccord Genuity forecasts a full year FY22 dividend of 21.00 cents and EPS of 76.00 cents.
At the last closing share price the estimated dividend yield is 1.11%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.88.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 109.3, implying annual growth of -31.5%.
Current consensus DPS estimate is 21.4, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 17.3.

Forecast for FY23:

Canaccord Genuity forecasts a full year FY23 dividend of 15.00 cents and EPS of 183.00 cents.
At the last closing share price the estimated dividend yield is 0.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.33.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 117.0, implying annual growth of 7.0%.
Current consensus DPS estimate is 20.9, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 16.2.

Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Goldman Sachs rates ((OZL)) as Neutral (3) –

OZ Minerals' June-quarter result fell short of Goldman Sachs' forecasts thanks to rising costs and a conveyor belt failure at Carrapateena. Recently lowered guidance was kept unchanged.

The corporate debt facility limit rose to $700m from $480m. The net cash balance was $82m.

EPS forecasts rise 9% in FY22, 4% in FY23 and 3% in FY24. Target price falls -2% to $20.1. Neutral rating.

This report was published on July 25, 2022.

Target price is $20.10 Current Price is $18.91 Difference: $1.19
If OZL meets the Goldman Sachs target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $19.12, suggesting upside of 1.1%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY22:

Goldman Sachs forecasts a full year FY22 dividend of -78.00 cents and EPS of 67.00 cents.
At the last closing share price the estimated dividend yield is – 4.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.22.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 109.3, implying annual growth of -31.5%.
Current consensus DPS estimate is 21.4, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 17.3.

Forecast for FY23:

Goldman Sachs forecasts a full year FY23 dividend of -91.00 cents and EPS of 178.00 cents.
At the last closing share price the estimated dividend yield is – 4.81%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.62.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 117.0, implying annual growth of 7.0%.
Current consensus DPS estimate is 20.9, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 16.2.

Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

S32    SOUTH32 LIMITED

Mining – Overnight Price: $3.86

Goldman Sachs rates ((S32)) as Buy (1) –

South32's June-quarter production met Goldman Sachs' forecast, as did costs.

Realised prices mostly outpaced and management will provide guidance at the FY22 results release, while pointing to a slower ramp-up of the Alumar smelter in Brazil and its Chilean Sierra Gorda copper mine.

EPS forecasts rise 9% in FY22 and fall -3% in FY23. Buy rating and $5.00 target price retained.

This report was published on July 25, 2022.

Target price is $5.00 Current Price is $3.86 Difference: $1.14
If S32 meets the Goldman Sachs target it will return approximately 30% (excluding dividends, fees and charges).
Current consensus price target is $5.34, suggesting upside of 38.4%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY22:

Goldman Sachs forecasts a full year FY22 dividend of 41.05 cents and EPS of 78.08 cents.
At the last closing share price the estimated dividend yield is 10.63%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.94.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 81.2, implying annual growth of N/A.
Current consensus DPS estimate is 34.6, implying a prospective dividend yield of 9.0%.
Current consensus EPS estimate suggests the PER is 4.8.

Forecast for FY23:

Goldman Sachs forecasts a full year FY23 dividend of 45.63 cents and EPS of 65.18 cents.
At the last closing share price the estimated dividend yield is 11.82%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.92.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 72.5, implying annual growth of -10.7%.
Current consensus DPS estimate is 34.0, implying a prospective dividend yield of 8.8%.
Current consensus EPS estimate suggests the PER is 5.3.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SDV    SCIDEV LIMITED

Industrial Sector Contractors & Engineers – Overnight Price: $0.32

Canaccord Genuity rates ((SDV)) as Downgrade to Speculative Buy from Buy (1) –

Canaccord Genuity lowers its rating to Speculative Buy from Buy for SciDev to reflect recent volatility and perceived heightened uncertainty. Recent lumpy earnings (albeit largely with a positive slant) have made forecasting difficult.

After reviewing June quarter financial and operating results, the broker believes a positive trajectory remains in place with revenue growing by 38% quarter-on-quarter. This outcome was largely driven by strength in the Energy vertical, combined with solid margins.

The target price falls to $0.46 from $0.75 after the analyst reduces medium-term assumptions while leaving FY23 largely unchanged. A higher discount rate is also used, due to balance sheet risk should the company's growth/cost out strategy not be achieved.

This report was published on July 27, 2022.

Target price is $0.46 Current Price is $0.32 Difference: $0.14
If SDV meets the Canaccord Genuity target it will return approximately 44% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY22:

Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 40.00.

Forecast for FY23:

Canaccord Genuity forecasts a full year FY23 dividend of 0.30 cents and EPS of 1.00 cents.
At the last closing share price the estimated dividend yield is 0.94%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.00.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

STO    SANTOS LIMITED

NatGas – Overnight Price: $7.38

Jarden rates ((STO)) as Overweight (2) –

Jarden assesses the June quarter trading results for Santos as a slight miss on production considered to be impacted by maintenance at PNG LNG.

The broker highlighted the strength in the free cash flow generation, reporting US$1.7bn in the first half.

Santos' rate of asset sales to degear the balance sheet may slow after the potential sale of the 5% stake in PNG LNG for an estimated $1.5bn according to Jarden.

The analysts highlight that forecasts remain dependent on changes in the oil and LNG prices as well as the capital expenditure on the Barossa, Dorado and Alaska projects.

Overweight rating maintained and $8.60 target price.

This report was published on August 21, 2022.

Target price is $8.60 Current Price is $7.38 Difference: $1.22
If STO meets the Jarden target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $9.63, suggesting upside of 30.5%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY22:

Jarden forecasts a full year FY22 dividend of 36.06 cents and EPS of 100.40 cents.
At the last closing share price the estimated dividend yield is 4.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.35.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 124.6, implying annual growth of N/A.
Current consensus DPS estimate is 33.9, implying a prospective dividend yield of 4.6%.
Current consensus EPS estimate suggests the PER is 5.9.

Forecast for FY23:

Jarden forecasts a full year FY23 dividend of 49.92 cents and EPS of 77.24 cents.
At the last closing share price the estimated dividend yield is 6.76%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.55.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 102.2, implying annual growth of -18.0%.
Current consensus DPS estimate is 31.2, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 7.2.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

TLX    TELIX PHARMACEUTICALS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $7.10

Jarden rates ((TLX)) as Buy (1) –

ILLUCCIX sales came in ahead of market consensus forecasts by 6.6% in the June quarter with overall 1H22 sales beating expectations by 20.7%, explains Jarden.

The balance of the sales for ILLUCCIX were generated from the US market, although the rest of the world experienced a major improvement, notes the analyst.

Jarden has delayed expectations for the launch of TLX-250 CDx by 18 months which is in line with Telix Pharmaceuticals' revised guidance and the pace of the clinical trials.

The broker adjusts earnings forecasts and valuations for a higher cost of capital and deferred cash flows for TLX-250 CDx.

A Buy rating is retained and the price target falls to $7.02 from $7.40.

This report was published on July 21, 2022.

Target price is $7.02 Current Price is $7.10 Difference: minus $0.08 (current price is over target).
If TLX meets the Jarden target it will return approximately minus 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company's fiscal year ends in December.

Forecast for FY22:

Jarden forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 21.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 33.81.

Forecast for FY23:

Jarden forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 5.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 136.54.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WDS    WOODSIDE ENERGY GROUP LIMITED

NatGas – Overnight Price: $32.84

Jarden rates ((WDS)) as Overweight (2) –

Jarden viewed the June quarter results from Woodside Energy as "messy" with the adoption of BHP Petroleum's reporting methods causing a lack of transparency for the transition from Woodside Energy's reporting to the new method.

The broker believes the quarter likely provided a beat were it not for the reporting issues.

Woodside Energy's 2022 guidance came in below Jarden's estimates after accounting for the BHP Petroleum adjustments and the analyst lowered the production forecasts to reflect the delay in Mad Dog Phase 2 and lower production for Atlantis oil production.

Earnings forecasts are reduced due to lower LNG contract prices and reduced production estimates.

An Overweight is maintained and the price target is reduced to $31.80 from $32.80.

This report was published on July 22, 2022.

Target price is $31.80 Current Price is $32.84 Difference: minus $1.04 (current price is over target).
If WDS meets the Jarden target it will return approximately minus 3% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $34.84, suggesting upside of 6.1%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY22:

Jarden forecasts a full year FY22 dividend of 223.27 cents and EPS of 409.93 cents.
At the last closing share price the estimated dividend yield is 6.80%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.01.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 484.3, implying annual growth of N/A.
Current consensus DPS estimate is 368.3, implying a prospective dividend yield of 11.2%.
Current consensus EPS estimate suggests the PER is 6.8.

Forecast for FY23:

Jarden forecasts a full year FY23 dividend of 203.86 cents and EPS of 337.54 cents.
At the last closing share price the estimated dividend yield is 6.21%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.73.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 381.2, implying annual growth of -21.3%.
Current consensus DPS estimate is 272.1, implying a prospective dividend yield of 8.3%.
Current consensus EPS estimate suggests the PER is 8.6.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WSP    WHISPIR LIMITED

Cloud services – Overnight Price: $1.12

Canaccord Genuity rates ((WSP)) as Hold (3) –

As part of Whispir's 4Q cash flow and activities update, management expects FY22 revenue to “exceed the upper-end guidance range” by around 5% and the earnings (EBITDA) loss to be less than anticipated.

Canaccord Genuity notes annual recurring revenue (ARR) momentum appears to be slowing modestly, though is in-line with historic trends. It's thought a targeted reduction in cash burn, along with organic ARR growth, will drive operating leverage over the next 18-24 months.

Because the broker adopts a higher discount rate (related to the perceived balance sheet risk if growth/cost out strategy is not achieved) the target falls to $1.70 from $2.00. The Hold rating is maintained.

This report was published on July 27, 2022.

Target price is $1.70 Current Price is $1.12 Difference: $0.58
If WSP meets the Canaccord Genuity target it will return approximately 52% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY22:

Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 7.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 14.93.

Forecast for FY23:

Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 15.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 7.09.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Wilsons rates ((WSP)) as Under Review (1) –

Whispir provided a 4Q22 update and guided for FY22.

Wilsons points out higher revenue and earnings guidance which may result in earnings forecast upgrades alongside the lowest cash outflow for the quarter falling -16% compared to the previous quarter.

The company did not disclose customer numbers but is thought to have over 1000.

The Overweight and $3.05 target price are Under Review.

This report was published on July 29, 2022.

Target price is $3.05 Current Price is $1.12 Difference: $1.93
If WSP meets the Wilsons target it will return approximately 172% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY22:

Wilsons forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 13.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 8.42.

Forecast for FY23:

Wilsons forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 11.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 9.82.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

---

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

As part of emerging new trends overseas, The Australian Broker Call *Extra* Edition also includes providers of sponsored research. Readers should bear in mind, sponsored research, while not necessarily of lower quality, has the embedded complication that the company that is the subject of the research has paid for this research. Providers of sponsored research that can potentially be included in this Report are Breakaway Research, Edison Investment Research, Independent Investment Research, NDF Research, Pitt Street Research, and TMT Analytics.

Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.

Click to view our Glossary of Financial Terms